Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway
Masahiro Hirayama(Mie University), Mineyoshi Aoyama(Nagoya City University)
Cited by 0
Related Papers
Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions
|Journal of Neuroinflammation|2020|23
The Inducible Nitric Oxide Synthase Pathway Promotes Osteoclastogenesis under Hypoxic Culture Conditions
|American Journal Of Pathology|2021|19
The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
|Cancers|2023|5
Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition
|Molecular and Clinical Oncology|2022|3